Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Luba

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Lancet. HIV|August 16, 2023
Malawi HIV progress: persistence and innovation are neededJames R Hargreaves, Maureen Luba, Jeffrey W Eaton
Journal of the International AIDS Society|November 22, 2021
HIV prevention today: do we still need a vaccine? A community perspectiveMaureen Luba, Ntando Yola, Rob Newells, et al.
Current Opinion in HIV and AIDS|November 28, 2018
Civil society demand for accountability to achieve the 90-90-90 targets: lessons from Eastern and Southern AfricaAsia Russell, Maureen Luba, Kenneth Mwehonge, et al.
Journal of the International AIDS Society|February 9, 2022
Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19Merle Henderson, Sarah Fidler, Beatriz Mothe, et al.
The Lancet. Global Health|December 5, 2025
The role of digital health and artificial intelligence in improving the reach and effectiveness of HIV prevention in AfricaAlinafe Mbewe, Hammond N Sarkwah, Olugbenga Ijaodola, et al.
The Lancet. HIV|December 5, 2025
Strengthening nationally led approaches to new product introduction for HIV preventionHasina Subedar, Nondumiso B Q Ncube, Herbert Kadama, et al.
Lancet (London, England)|December 7, 2019
The complex challenges of HIV vaccine development require renewed and expanded global commitmentLinda-Gail Bekker, Roger Tatoud, Francois Dabis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Lancet. HIV|August 16, 2023
Malawi HIV progress: persistence and innovation are neededJames R Hargreaves, Maureen Luba, Jeffrey W Eaton
Journal of the International AIDS Society|November 22, 2021
HIV prevention today: do we still need a vaccine? A community perspectiveMaureen Luba, Ntando Yola, Rob Newells, et al.
Current Opinion in HIV and AIDS|November 28, 2018
Civil society demand for accountability to achieve the 90-90-90 targets: lessons from Eastern and Southern AfricaAsia Russell, Maureen Luba, Kenneth Mwehonge, et al.
Journal of the International AIDS Society|February 9, 2022
Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19Merle Henderson, Sarah Fidler, Beatriz Mothe, et al.
The Lancet. Global Health|December 5, 2025
The role of digital health and artificial intelligence in improving the reach and effectiveness of HIV prevention in AfricaAlinafe Mbewe, Hammond N Sarkwah, Olugbenga Ijaodola, et al.
The Lancet. HIV|December 5, 2025
Strengthening nationally led approaches to new product introduction for HIV preventionHasina Subedar, Nondumiso B Q Ncube, Herbert Kadama, et al.
Lancet (London, England)|December 7, 2019
The complex challenges of HIV vaccine development require renewed and expanded global commitmentLinda-Gail Bekker, Roger Tatoud, Francois Dabis, et al.
Pageof 1